CompoAtlas

Ultra Violette Future Fluid Superlight Mineral Skinscreen

Natural health product licensed in Canada

Licence holder
Grace & Fire Pty Ltd
NPN or DIN-HM
80134070
Status
Active licence
Licence date
5 September 2024
Revision date
Not provided
Form
Lotion
Route of administration
Topique
Application type
Officinale

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the source
Oxyde de zinc

Source : Oxyde de zinc

20 %

Non-medicinal ingredients

Ethylhexyl Méthoxycrylène, Benzoate d'alkyle en C12 à 15, C.I. 77492, C.I. 77491, Silicate de magnésium et d'aluminium, Acide poly(hydroxystéarique), Isomérate de saccharide, Cétyl phosphate de potassium, Poly(taurate d'acryloyldiméthyle) d'ammonium, Eau, Isostéarate de poly(glycéryle-4), Citrate de sodium, Triéthoxycaprylylsilane, Hydroxyde de sodium, Triglycéride caprylique/caprique, Acide citrique, C.I. 77499, Adipate de di-isopropyle, Acétate de tocophéryle, Octénylsuccinate d'amidon aluminium, Citrate d'oléate de glycéryle, Hydroxyacétophénone, D-glucoside de décyle, Phénoxyéthanol, Squalane, Coco-caprylate/caprate, Propanediol, Acide lactique

PopulationAgeQuantity per servingFrequency
Population not specifiedminimum: 0.5 yearsNot specifiedNot specified

Uses authorised in Canada

Text supplied in English because no French text is available.

Broad spectrum. Sun Protection Factor 50+/SPF 50+.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80134070

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line